Skip to main content

Bruker Value Stock - Dividend - Research Selection


ISIN: US1167941087 , WKN: 813534

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Bruker (BRKR) Advances Novel 4D-Proteomics Capabilities

Bruker's (BRKR) commitment to innovation and customer support makes it a great partner and helps achieve its mission of translating nature into medicine.

Bruker Introduces Novel 4D-Proteomics™ timsTOF® Capabilities

BUSAN, South Korea, September 18, 2023--At the 22nd Human Proteome Organization World Congress 2023, Bruker Corporation (Nasdaq: BRKR) today announced advances in instrumental methods, consumables and software for 4D-Proteomics, MALDI HiPLEX-IHC spatial tissue proteomics, 4D-Lipidomics and 4D-Metabolomics.

Interesting BRKR Put And Call Options For November 17th

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Bruker (BRKR) Inks Fraport Framework Contract for ETD Systems

Bruker's (BRKR) DE-tector flex system uses a non-radioactive ionization source and is approved by national regulatory bodies and ECAC.

Here's Why You Should Retain Bruker (BRKR) Stock for Now

Investors continue to be optimistic about Bruker (BRKR), backed by the performance of the CALID and NANO groups and strength in acquisitions.

Bruker Announces New Fraport AG Framework Contract for ETD Systems

FRANKFURT, Germany, September 07, 2023--Fraport AG has announced the procurement decision in favor of Bruker for the provision of up to 220 DE-tector™ flex explosives and narcotics trace detectors to support their airport security measures. The installations are planned over a multi-year period from 2023 to 2027 to modernize the screening of passengers at Germany’s busiest airport FRA. The next-generation, high-performance Bruker DE-tector flex systems are intended to replace earlier-generation

Dragonfly Energy Leverages Cutting-Edge Lithium Battery Research Instrumentation from Bruker

Dragonfly Energy has made a significant investment in high-end battery research equipment from BrukerThe Bruker equipment purchased and used by Dragonfly Energy utilizes numerous advanced technologies, such as AFM, FT-IR, NMR, Raman, XRD, and XRF, among others, to study lithium battery cells at a fundamental levelThis technology is expected to enable Dragonfly Energy to optimize the performance of the Company’s previously announced domestically manufactured lithium battery cells RENO, Nev., Sept

Dragonfly Energy leverages lithium battery research instrumentation from Bruker

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.